Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells
- 31 January 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 24 (11), 1873-1881
- https://doi.org/10.1038/sj.onc.1208404
Abstract
RUNX transcription factors are important in development and in numerous types of human cancer. They act as either transcriptional activators or repressors and can be proto-oncogenes or tumour suppressors. Understanding their regulation and interaction may explain how RUNX factors contribute to such different and often opposing biological processes. We show that RUNX3 regulates RUNX1 expression, contributing to the mutually exclusive expression of RUNX3 and RUNX1 in human B lymphoid cell lines. RUNX3 repressed the RUNX1 P1 promoter by binding specifically to conserved RUNX sites near the transcription start of the promoter. siRNA inhibition of RUNX3 in lymphoblastoid cells resulted in increased RUNX1 expression, indicating that continuous expression of physiological levels of RUNX3 is required to maintain repression. Furthermore, expression of RUNX3 was required for efficient proliferation of B cells immortalized by Epstein–Barr virus. Cross-regulation between different RUNX family members is therefore a means of controlling RUNX protein expression and must now be considered in the interpretation of pathological changes due to loss of RUNX3 tumour suppressor function or following gene duplication or translocation events.Keywords
This publication has 49 references indexed in Scilit:
- Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell linesOncogene, 2004
- A Serrate-expressing signaling center controlsDrosophilahematopoiesisGenes & Development, 2003
- Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte DevelopmentCell, 2002
- c-Myc Overcomes Cell Cycle Inhibition by CBFβ-SMMHCCancer Biology & Therapy, 2002
- Expression of Transcription Factor AML-2 (RUNX3, CBFα-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation PhenotypeJournal of Virology, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B CellsJournal of Virology, 2001
- BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instabilityOncogene, 1998
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- Establishment in continuous culture of a new type of lymphocyte from a “burkitt‐like” malignant lymphoma (line d.g.‐75)International Journal of Cancer, 1977